Orthotopic liver transplantation in Jehovah's Witnesses

Current Anaesthesia and Critical Care

Volumn 19, Issue 1, 2008, Pages 34-41

  Yang, Lucy ^a   Jankovic, Zorica ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Blood transfusion; Liver transplantation; Survival

Indexed keywords

AMINOCAPROIC ACID; ANTICOAGULANT AGENT; ANTIFIBRINOLYTIC AGENT; APROTININ; BERIPLEX; CELLULOSE; COLLAGEN; ERYTHROPOIETIN; FIBRIN GLUE; FOLIC ACID; IRON; PLASMA SUBSTITUTE; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT HEMOGLOBIN; SEALANT; SERINE PROTEINASE INHIBITOR; TRANEXAMIC ACID; UNCLASSIFIED DRUG;

ANESTHESIA INDUCTION; ANESTHESIOLOGICAL TECHNIQUES; ANTIINFLAMMATORY ACTIVITY; ARGON PLASMA COAGULATION; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; BODY TEMPERATURE; CENTRAL VENOUS PRESSURE; CLINICAL PROTOCOL; COLLOID; CRYSTALLOID; DISEASE TRANSMISSION; DRUG MEGADOSE; EVIDENCE BASED MEDICINE; HEALTH CARE NEED; HEMODILUTION; HUMAN; HYPOTENSION; IMMUNOSUPPRESSIVE TREATMENT; INTERDISCIPLINARY COMMUNICATION; JEHOVAH'S WITNESS; LIVER TRANSPLANTATION; OPERATION DURATION; PATIENT ATTITUDE; PATIENT CARE; PATIENT MONITORING; PERIOPERATIVE PERIOD; PEROPERATIVE CARE; PHLEBOTOMY; PLASMA TRANSFUSION; POSTOPERATIVE CARE; PREOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REOPERATION; REPEATED DRUG DOSE; RISK ASSESSMENT; RISK REDUCTION; SALVAGE THERAPY; SINGLE DRUG DOSE; THROMBOCYTE MEMBRANE; THROMBOEMBOLISM; TREATMENT PLANNING; VITAMIN SUPPLEMENTATION;

EID: 38649096656     PISSN: 09537112     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cacc.2007.09.001     Document Type: Article

References (47)

1. de Boer M.T., Molenaar I.Q., Hendriks H.G., Slooff M.J., and Porte R.J. Minimizing blood loss in liver transplantation: progress through research and evolution of techniques. Dig Surg 22 4 (2005) 265-275
2. Detry O., Roover A.D., Delwaide J., Kaba A., Joris J., Damas P., et al. Liver transplantation in Jehovah's witnesses. Transpl Int 18 8 (2005) 929-936
3. Jabbour N., Gagandeep S., Mateo R., Sher L., Genyk Y., and Selby R. Transfusion free surgery: single institution experience of 27 consecutive liver transplants in Jehovah's Witnesses. J Am Coll Surg 201 3 (2005) 412-417
4. Snook N.J., O'Beirne H.A., Enright S., Young Y., and Bellamy M.C. Use of recombinant human erythropoietin to facilitate liver transplantation in a Jehovah's Witness. Br J Anaesth 76 5 (1996) 740-743
5. Hendriks H.G., van der Meer J., de Wolf J.T., Peeters P.M., Porte R.J., de Jong K., et al. Intraoperative blood transfusion requirement is the main determinant of early surgical re-intervention after orthotopic liver transplantation. Transpl Int 17 11 (2005) 673-679
6. Watch Tower Bible and Tract Society of Pennsylvania. Jehovah's Witnesses-who are they? What do they believe? (1997), Watchtower Bible and Tract Society, New York p. 25
7. Watch Tower Bible and Tract Society of Pennsylvania. How can blood save your life? (1990), Watch Tower Bible and Tract Society, London p. 3
8. New World Bible Translation Committee. New world translation of the Holy Scriptures (1984), Watch Tower Bible and Tract Society, New York
9. Watch Tower Bible and Tract Society. A godly view of life. In: What does the Bible really teach? New York: Watch Tower Bible and Tract Society; 2005, p. 125.
10. Watch Tower Bible and Tract Society of Pennsylvania. Questions from readers. Watch Tower 121 (2000) 29
11. Association of Anaesthetists of Great Britain and Ireland. Management of anaesthesia for Jehovah's Witnesses (1999), Association of Anaesthetists of Great Britain and Ireland, London
12. Marsh J.C., and Bevan D.H. Haematological care of the Jehovah's Witness patient. Br J Haematol 119 1 (2002) 25-37
13. Milligan L.J., and Bellamy M.C. Anaesthesia and critical care of Jehovah's Witnesses. Contin Educ Anaesth Crit Care Pain 4 2 (2004) 35-39
14. Cazzola M., Mercuriali F., and Brugnara C. Use of recombinant human erythropoietin outside the setting of uremia. Blood 89 12 (1997) 4248-4267
15. Goodnough L.T., Monk T.G., and Andriole G.L. Erythropoietin therapy. N Engl J Med 336 13 (1997) 933-938
16. Majeski J. Advances in general and vascular surgical care of Jehovah's Witnesses. Int Surg 85 3 (2000) 257-265
17. Miyamoto S., Polak W.G., Geuken E., Peeters P.M., de Jong K.P., Porte R.J., et al. Liver transplantation with preservation of the inferior vena cava. A comparison of conventional and piggyback techniques in adults. Clin Transplant 18 6 (2004) 686-693
18. Feng S., Goodrich N.P., Bragg-Gresham J.L., Dykstra D.M., Punch J.D., DebRoy M.A., et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 6 4 (2006) 783-790
19. Mahdy A.M., and Webster N.R. Perioperative systemic haemostatic agents. Br J Anaesth 93 6 (2004) 842-858
20. Massicotte L., Lenis S., Thibeault L., Sassine M.P., Seal R.F., and Roy A. Effect of low central venous pressure and phlebotomy on blood product transfusion requirements during liver transplantations. Liver Transpl 12 1 (2006) 117-123 Erratum in: Liver Transpl 2006 Apr;12(4):694
21. Gal R., Cundrle I., Seidlova J., Kala Z., and Prochazka V. Anaesthesia management of major hepatic resections without application of allogeneic blood. Bratisl Lek Listy 104 7-8 (2003) 243-246
22. Jabbour N., Gagandeep S., Mateo R., Sher L., Strum E., Donovan J., et al. Live donor liver transplantation without blood products: strategies developed for Jehovah's Witnesses offer broad application. Ann Surg 240 2 (2004) 350-357
23. Training and competency for trent intra-operative cell salvage. Acute Normovolemic Haemodilution. Available from: 〈www.vptest.co.uk/TACTICS2005/aut04/02aut04.htm〉; 2005 [accessed 11.05.06].
24. Saricaoglu F., Akinci S.B., Celiker V., and Aypar U. The effect of acute normovolemic hemodilution and acute hypervolemic hemodilution on coagulation and allogeneic transfusion. Saudi Med J 26 5 (2005) 792-798
25. Xia V.W., and Steadman R.H. Antifibrinolytics in orthotopic liver transplantation: current status and controversies. Liver Transpl 11 1 (2005) 10-18
26. Kovesi T., and Royston D. Pharmacological approaches to reducing allogeneic blood exposure. Vox Sang 84 1 (2003) 2-10
27. Porte R.J., Molenaar I.Q., Begliomini B., Groenland T.H., Januszkiewicz A., Lindgren L., et al. Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study. EMSALT Study Group. Lancet 355 9212 (2000) 1303-1309
28. Findlay J.Y., Rettke S.R., Ereth M.H., Plevak D.J., Krom R.A., and Kufner R.P. Aprotinin reduces red blood cell transfusion in orthotopic liver transplantation: a prospective, randomized, double-blind study. Liver Transpl 7 9 (2001) 802-807
29. Porte R.J., and Slooff M.J. Aprotinin: safe and effective in all patients undergoing orthotopic liver transplantation?. Liver Transpl 7 9 (2001) 808-810
30. Dalmau A., Sabate A., Koo M., Bartolome C., Rafecas A., Figueras J., et al. The prophylactic use of tranexamic acid and aprotinin in orthotopic liver transplantation: a comparative study. Liver Transpl 10 2 (2004) 279-284
31. Dalmau A., Sabate A., Koo M., Bartolome C., Rafecas A., Figueras J., et al. The prophylactic use of tranexamic acid and aprotinin in orthotopic liver transplantation: a comparative study. Liver Transpl 10 2 (2004) 279-284
32. Molenaar I.Q., Veldman M., Begliomini B., Groenland H.N., Januszkiewicz A., Lindgren L., et al. Improved early graft survival in patients receiving aprotinin during orthotopic liver transplantation. Transplant Proc 33 1-2 (2001) 1345-1346
33. Molenaar I.Q., and Porte R.J. Aprotinin and thromboembolism in liver transplantation: is there really a causal effect?. Anesth Analg 94 5 (2002) 1367-1368 [author reply 1368]
34. Kresie L. Artificial blood: an update on current red cell and platelet substitutes. Proc (Bayl Univ Med Cent) 14 2 (2001) 158-161
35. Prowse C.V. Alternatives to standard blood transfusion: availability and promise. Transfus Med 9 4 (1999) 287-299
36. Giannini E.G. Review article: thrombocytopenia in chronic liver disease and pharmacologic treatment options. Aliment Pharmacol Ther 23 8 (2006) 1055-1065
37. Planinsic R.M., van der Meer J., Testa G., Grande L., Candela A., Porte R.J., et al. Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease. Liver Transpl 11 8 (2005) 895-900
38. Lodge J.P., Jonas S., Jones R.M., Olausson M., Mir-Pallardo J., Soefelt S., et al. Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation. Liver Transpl 11 8 (2005) 973-979
39. Niemann C.U., Behrends M., Quan D., Eilers H., Gropper M.A., Roberts J.P., et al. Recombinant factor VIIa reduces transfusion requirements in liver transplant patients with high MELD scores. Transfus Med 16 2 (2006) 93-100
40. Hendriks H.G., Meijer K., de Wolf J.T., Klompmaker I.J., Porte R.J., de Kam P.J., et al. Reduced transfusion requirements by recombinant factor VIIa in orthotopic liver transplantation: a pilot study. Transplantation 71 3 (2001) 402-405
41. Evans G., Luddington R., and Baglin T. Beriplex P/N reverses severe warfarin-induced overanticoagulation immediately and completely in patients presenting with major bleeding. Br J Haematol 115 4 (2001) 998-1001
42. Smoller B.R., and Kruskall M.S. Phlebotomy for diagnostic laboratory tests in adults. Pattern of use and effect on transfusion requirements. N Engl J Med 314 19 (1986) 1233-1235
43. Schalte G., Janz H., Busse J., Jovanovic V., Rossaint R., and Kuhlen R. Life-threatening postoperative blood loss in a Jehovah's Witness, treated with high-dose erythropoietin. Br J Anaesth 94 4 (2005) 442-444
44. Mozes M.F., Spigos D.G., Pollak R., Abejo R., Pavel D.G., Tan W.S., et al. Partial splenic embolization, an alternative to splenectomy-results of a prospective, randomized study. Surgery 96 4 (1984) 694-702
45. Sockrider C.S., Boykin K.N., Green J., Marsala A., Mladenka M., McMillan R., et al. Partial splenic embolization for hypersplenism before and after liver transplantation. Clin Transplant 16 Suppl. 7 (2002) 59-61
46. Seu P., Neelankanta G., Csete M., Olthoff K.M., Rudich S., Kinkhabwala M., et al. Liver transplantation for fulminant hepatic failure in a Jehovah's Witness. Clin Transplant 10 5 (1996) 404-407
47. Heier H.E., Bugge W., Hjelmeland K., Soreide E., Sorlie D., and Haheim L.L. Transfusion vs alternative treatment modalities in acute bleeding: a systematic review. Acta Anaesthesiol Scand 50 8 (2006) 920-931